Haematopoietic stem-cell transplantation in multiple myeloma
- 31 March 1996
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 22 (2) , 119-125
- https://doi.org/10.1016/s0305-7372(96)90031-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- A new staging system for multiple myeloma based on the number of S- phase plasma cellsBlood, 1995
- Why better prognostic factors for multiple myeloma are needed [editorial] [see comments]Blood, 1994
- The Treatment of Multiple MyelomaNew England Journal of Medicine, 1994
- Limited value of myeloablative therapy for late multiple myelomaBlood, 1994
- Prognostic factors in multiple myeloma: role of ?2-microglobulin and thymidine kinaseJournal of Molecular Medicine, 1993
- Myeloma, melphalan, and meta-analysis.Journal of Clinical Oncology, 1992
- A plea to overcome the concept of “staging” and related inadequacy in multiple myelomaEuropean Journal of Haematology, 1991
- Long‐term prognostic value of serum β2microglobulin in myelomatosisBritish Journal of Haematology, 1990
- VAD‐based regimens as primary treatment for multiple myelomaAmerican Journal of Hematology, 1990
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983